Clements Ian 4
4 · Mirum Pharmaceuticals, Inc. · Filed Nov 29, 2021
Insider Transaction Report
Form 4
Clements Ian
SVP Finance & Communications
Transactions
- Purchase
Common Stock
2021-11-24$14.40/sh+700$10,080→ 17,811 total - Purchase
Common Stock
2021-11-26$13.90/sh+750$10,425→ 18,561 total
Footnotes (1)
- [F1]The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.